About
This medication is a specialized formulation of paclitaxel, an antineoplastic agent, designed to enhance drug delivery and potentially reduce certain side effects associated with conventional paclitaxel. It works by stabilizing microtubules, thereby disrupting the dynamic equilibrium necessary for cell division and leading to cell cycle arrest and apoptosis in rapidly dividing cancer cells. The unique formulation, often involving albumin-bound nanoparticles or liposomes, allows for improved solubility, enhanced tumor penetration, and a reduced incidence of severe hypersensitivity reactions compared to solvent-based paclitaxel, eliminating the need for pre-medication. Administered intravenously, it is a valuable treatment option for various solid tumors, including metastatic breast cancer, non-small cell lung cancer, and pancreatic cancer, offering a more tolerable and effective therapeutic profile.
Uses
- Treatment of metastatic breast cancer.
- Management of non-small cell lung cancer.
- Therapy for advanced pancreatic cancer.
- Treatment of other solid tumors where paclitaxel is indicated.
Directions For Use
Administer intravenously under the supervision of a qualified oncologist. Dosage and infusion schedule are determined by the specific cancer type and patient's condition.
Benefits
- Effective against various solid tumors.
- Reduced incidence of severe hypersensitivity reactions.
- Potentially improved tumor penetration.
- Does not require pre-medication with corticosteroids and antihistamines.
- Offers a treatment option for patients intolerant to conventional paclitaxel.
- Can be used in combination regimens.
Side Effects
- Myelosuppression (neutropenia, anemia, thrombocytopenia)
- Peripheral neuropathy
- Fatigue
- Nausea and vomiting
- Alopecia (hair loss)
- Muscle and joint pain
- Diarrhea
- Edema
- Rash
- Mucositis
- Liver enzyme elevations
- Injection site reactions
Safety Measures
- Alcohol - Alcohol should be avoided during chemotherapy as it can exacerbate side effects like nausea, fatigue, and liver strain, and may interact with other medications.
- Pregnancy - Contraindicated in pregnancy due to significant risk of fetal harm. Women of childbearing potential must use effective contraception.
- Breastfeeding - Breastfeeding is contraindicated during paclitaxel therapy and for a period after, due to the potential for serious adverse reactions in the infant.
- Liver - Dose adjustments are necessary in patients with liver impairment. Use with extreme caution and monitor liver function closely.
- Kidney - No specific dose adjustment is generally required for mild to moderate renal impairment, but caution is advised.
- Lung - Rare but serious pulmonary toxicity, including interstitial pneumonia, has been reported. Monitor for respiratory symptoms.
Disclaimer
MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.
Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.
Our goal is to complement, not replace, the essential doctor-patient relationship.
| Shipping Cost |
|
| Shop Location | Assam, India |

No comments found for this product. Be the first to comment!